News
Declines in ESA hyporesponsiveness are significantly associated with increased malignancy risk in patients with CKD not on dialysis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback